Organization | Becton Dickinson

Becton Dickinson Report issue

For profit Phase 2 Phase 3 Phase 4

Founded: East Rutherford NJ United States (1897)

Status: No NME R&D (1897)

Organization Overview

First Clinical Trial

2003

NCT00706693

First Marketed Drug

1976

hexachlorophene

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BECTON DICKINSON | Becton, Dickinson and Company | BECTON DICKINSON CO

Active Ingredients

Marketed Drugs (4)

Key: Becton Dickinson (1) Acquired (3)

chlorhexidine (hibitane) (2000)

hexachlorophene (1976)

isopropyl alcohol (2000)

povidone-iodine (betadine) (1985)

Drugs in Phase 4 Trials (8)

Key: Becton Dickinson (5) Acquired (3)

chlorhexidine (hibitane) (7 trials)

exenatide (byetta) (1 trial)

insulin glargine (toujeo) (2 trials)

insulin human (humulin) (2 trials)

isopropyl alcohol (4 trials)

povidone-iodine (betadine) (2 trials)

sitagliptin (januvia) (2 trials)

tamsulosin (flomax) (1 trial)

Drugs in Phase 3 Trials (3)

Key: Becton Dickinson (2) Acquired (1)

liraglutide (victoza) (1 trial)

sodium chloride (2 trials)

sufonylurea (1 trial)

Drugs in Phase 2 Trials (5)

Key: Becton Dickinson (1) Acquired (4)

aripiprazole (abilify) (1 trial)

insulin lispro (humalog) (1 trial)

nivolumab (opdivo) (1 trial)

octenidine (3 trials)

talimogene laherparepvec (Imlygic) (1 trial)

Drugs in Other Trials (10)

Key: Becton Dickinson (2) Acquired (8)

alfentanil (alfenta) (1 trial)

desflurane (suprane) (1 trial)

fentanyl (Innovar) (1 trial)

glucose (1 trial)

isoflurane (forane) (1 trial)

mupirocin (bactroban) (1 trial)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

sevoflurane (ultane) (1 trial)

sufentanil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetes Mellitus, Type 2 (Phase 3)

Hernia (Phase 4)

Hernia, Inguinal (Phase 4)

Urinary Retention (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 19
# of Trial APIs: 26